Daniel Bengtsson

Kalmar, H, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Correction: Genome‑wide methylation profiling differentiates benign from aggressive and metastatic pituitary neuroendocrine tumors.

Correction: Genome‑wide methylation profiling differentiates benign from aggressive and metastatic pituitary neuroendocrine tumors.

Journal: Acta neuropathologica

Published: January 03, 2025

Socioeconomic status and its association with outcome in patients with Cushing's disease.

Socioeconomic status and its association with outcome in patients with Cushing's disease.

Journal: European journal of endocrinology

Published: September 03, 2024

Genome-wide methylation profiling differentiates benign from aggressive and metastatic pituitary neuroendocrine tumors.

Genome-wide methylation profiling differentiates benign from aggressive and metastatic pituitary neuroendocrine tumors.

Journal: Acta neuropathologica

Published: July 20, 2024

Increased Mortality Persists after Treatment of Cushing's Disease: A Matched Nationwide Cohort Study.

Increased Mortality Persists after Treatment of Cushing's Disease: A Matched Nationwide Cohort Study.

Journal: Journal of the Endocrine Society

Published: February 02, 2022

Psychotropic Drugs in Patients with Cushing's Disease Before Diagnosis and at Long-Term Follow-Up: A Nationwide Study.

Psychotropic Drugs in Patients with Cushing's Disease Before Diagnosis and at Long-Term Follow-Up: A Nationwide Study.

Journal: The Journal of clinical endocrinology and metabolism

Published: December 13, 2020

Corticotroph Aggressive Pituitary Tumors and Carcinomas Frequently Harbor ATRX Mutations.

Corticotroph Aggressive Pituitary Tumors and Carcinomas Frequently Harbor ATRX Mutations.

Journal: The Journal of clinical endocrinology and metabolism

Published: July 20, 2020

Tumoral MGMT content predicts survival in patients with aggressive pituitary tumors and pituitary carcinomas given treatment with temozolomide.

Tumoral MGMT content predicts survival in patients with aggressive pituitary tumors and pituitary carcinomas given treatment with temozolomide.

Journal: Endocrine

Published: July 13, 2018

Corticotroph Pituitary Carcinoma in a Patient With Lynch Syndrome (LS) and Pituitary Tumors in a Nationwide LS Cohort.

Corticotroph Pituitary Carcinoma in a Patient With Lynch Syndrome (LS) and Pituitary Tumors in a Nationwide LS Cohort.

Journal: The Journal of clinical endocrinology and metabolism

Published: June 20, 2017

Does influenza A virus infection affect movement behaviour during stopover in its wild reservoir host?

Does influenza A virus infection affect movement behaviour during stopover in its wild reservoir host?

Journal: Royal Society open science

Published: November 18, 2015

Long-term outcome and MGMT as a predictive marker in 24 patients with atypical pituitary adenomas and pituitary carcinomas given treatment with temozolomide.

Long-term outcome and MGMT as a predictive marker in 24 patients with atypical pituitary adenomas and pituitary carcinomas given treatment with temozolomide.

Journal: The Journal of clinical endocrinology and metabolism

Published: February 04, 2015

Long-term variation in influenza A virus prevalence and subtype diversity in migratory mallards in northern Europe.

Long-term variation in influenza A virus prevalence and subtype diversity in migratory mallards in northern Europe.

Journal: Proceedings. Biological sciences

Published: February 28, 2014

Movements, home-range size and habitat selection of mallards during autumn migration.

Movements, home-range size and habitat selection of mallards during autumn migration.

Journal: PloS one

Published: January 16, 2014

Showing 1-12 of 16

Last Updated: 09/26/2026